© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
CORRESPONDENCE |
Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Correspondence to: Peter C. Gøtzsche, MD, DrMedSci, MSc, The Nordic Cochrane Centre, Rigshospitalet, Dept. 7112, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark (e-mail: pcg@cochrane.dk)
| The first 10% of the full text of this article appears below. |
Baxter et al. (1) report that about half the women undergoing lumpectomy for ductal carcinoma in situ do not get radiotherapy. The authors consider this to be undertreatment, because several studies have shown that radiotherapy reduces the risk of local recurrence and of invasive cancer. But the
Related Correspondence
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1258.
J Natl Cancer Inst 2004 96: 1258-1259.
J Natl Cancer Inst 2004 96: 1259-1260.
This article has been cited by other articles:
![]() |
B. D. Smith, B. G. Haffty, T. A. Buchholz, G. L. Smith, D. H. Galusha, J. E. Bekelman, and C. P. Gross Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst, September 20, 2006; 98(18): 1302 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Li, J. R. Daling, and K. E. Malone Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001 Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1008 - 1011. [Abstract] [Full Text] [PDF] |
||||

